Global Protein Purification and Isolation Market is expected to reach USD 10,328.02 million by 2025 from USD 5,580.31 million in 2017, at a CAGR of 8.1% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025. 
Access Full Report: https://www.databridgemarketresearch.com/reports/global-protein-purification-isolation-market The global protein purification and isolation market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. Merck KGaA dominated the protein purification and isolation market accounting for a highest market share in 2017, followed by GE Healthcare and ThermoFisher Scientific Inc. Other players in this market include are QIAGEN, BIO-RAD LABORATORIRES INC., Agilent, Promega Corporation, Purolite, BioVision, Inc., Expedeon Ltd. among others. Merck KGaA: Merck KGaA, founded in 1668 and headquartered in Darmstadt, Germany. Merck KGaA, is a leading science and technology company in healthcare, life science and performance materials. It operates as EMD Serono in the Biopharma business, as MilliporeSigma in the Life Science business, and as EMD Performance Materials in the materials business. The healthcare business segment designs and develops medicines and intelligent devices that provide ongoing care for patients beyond the treatment. The life science business segment is engaged in drug discovery and development to manufacturing and diagnostics. The performance materials develop specialty chemicals and high-tech materials for particularly demanding applications in the diagnosis, treatment of cardiovascular diseases. GE HEALTHCARE: GE HEALTHCARE, founded in 2004 and headquartered Little Chalfont, United Kingdom. GE healthcare provides transformational medical technologies and services. GE health care operates through three business segments health care systems, life sciences and healthcare digital. The healthcare systems segment offers a wide range of products for diagnostic imaging and clinical systems. Diagnostic imaging systems such as digital mammography, X-ray, computed tomography (CT), surgical and interventional imaging, magnetic resonance (MR) and molecular imaging technologies. Clinical systems comprises of ultrasound, bone densitometry, electrocardiography (ECG), patient monitoring, incubators, infant warmers, respiratory care, and anaesthesia management. ThermoFisher Scientific Inc.: ThermoFisher Scientific Inc., founded in 1956 and headquartered at Massachusetts, U.S. The company operates its business through four segments namely, laboratory products & services, life sciences & solutions, analytical instruments & speciality diagnostic. Life sciences solutions provides an extensive portfolio of instruments, reagents and consumables used in medical research and biological, discovery and production of vaccines and new drugs as well as diagnosis of diseases. Analytical instruments segment provides a broad offering of consumables, instruments, software and services that are used for a range of applications in the laboratory, on the production line and in the field. Specialty diagnostics segment provides a wide range of diagnostic test kits, reagents, instruments and associated products used to increase the speed and accuracy of diagnoses. The products for protein purification & isolation are offered by the product category protein biology and industrial & applied science.
